John leads the Scientific Services Division (SSD) of Blis Technologies (https://blis.co.nz/). Blis is the developer of probiotics (good bacteria) for application to the oral cavity and skin. The SSD focuses on the core research and development behind both current and new probiotic strains. John has gained experience working in a commercial scientific setting ensuring that our R and D activities across core research, development requirements, clinical trials regulatory, IP, fermentation, and quality control comply with the appropriate requirements. Further, John holds an adjunct role in the Dept Microbiology and Immunology at the University of Otago and continues to bridge academic with commercial science. https://www.linkedin.com/in/johnhalenz/ https://blis.co.nz/ @blistechnologies

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related